Bafna Pharmaceuticals Ltd.

View in App
85.30 ▼0%

25 September 2023, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bafnapharma.com
Market Cap 201.79 Cr.
Enterprise Value(EV) 224.71 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 6.90 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 12.36 Trailing Twelve Months Ending 2023-06
Industry PE 38.47 Trailing Twelve Months Ending 2023-06
Book Value / Share 33.73 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.53 Calculated using Price: 85.30
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.37 Cr. 23,656,335 Shares
FaceValue 10
About Bafna Pharmaceuticals Ltd.
Bafna Pharmaceuticals was incepted by Bafna Mahaveer Chand in 1981 as a proprietary concern. It was converted into a public limited company on 28th march 1995. The company started its own manufacturing unit in October 1984.

Bafna Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bafna Pharmaceuticals Ltd. Performance

View details >>
1 Day
1 Week
-4.96%
1 Month
-18.44%
3 Month
-20.80%
6 Month
+6.62%
1 Year
-17.10%
2 Year
-32.99%
5 Year
+515.88%
10 Year
+203.02%

Bafna Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.25 9.22 -18.69 -37.05 -40.37 -64.36 -22.93 22.26 8.61
Return on Capital Employed (%) 9.15 12.56 -0.04 -5.98 -6.97 -20.90 -2.95 10.62 8.39
Return on Assets (%) 0.57 2.99 -6.58 -10.49 -11.17 -15.90 -1.96 7.40 5.83

Bafna Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 69 72 59 45 41 21 51 57 63 73
Non Curr. Liab. 27 14 39 42 28 29 3 5 11 10
Curr. Liab. 126 100 87 81 59 71 17 24 16 46
Minority Int.
Equity & Liab. 223 185 185 167 128 121 71 86 90 130
Non Curr. Assets 66 68 65 90 79 72 35 37 39 42
Curr. Assets 149 117 119 77 48 48 36 50 51 87
Misc. Exp. not W/O 8 1
Total Assets 223 185 185 167 128 121 71 86 90 130

Bafna Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 178 143 85 65 47 44 42 71 85 140
Other Income 1 1 1 1 31 0 0 1 2 4
Total Income 179 144 87 66 78 44 43 72 87 145
Total Expenditure -156 -117 -83 -70 -82 -57 -41 -61 -74 -120
PBIDT 23 26 4 -4 -4 -13 1 11 14 24
Interest -12 -12 -12 -11 -7 -2 0 -1 -1 -2
Depreciation -8 -5 -4 -4 -4 -3 -3 -4 -5 -5
Taxation -1 0 0 1 -2 -2 0
Exceptional Items -3 -2
PAT 1 6 -12 -18 -16 -20 -2 6 5 16
Adjusted EPS 1 3 -7 -10 -7 -8 -8 2 2 7

Bafna Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 35 1 9 -3 20 -7 -1 -34 -14 8
Cash Fr. Inv. -6 -5 56 -1 -14 38 4 33 -5 -5
Cash Fr. Finan. -11 -14 -66 4 -5 -31 -2 7 12 -4
Net Change 18 -18 0 0 0 0 6 -7 -2
Cash & Cash Eqvt 21 2 2 3 3 3 3 8 2 0

Bafna Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 90.39 90.40 90.42 90.42 90.12 90.00 90.02 90.00 90.00
Public 9.61 9.60 9.58 9.58 9.88 10.00 9.98 10.00 10.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bafna Pharmaceuticals Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Closure of Trading Window
Pursuant to the provisions of SEBI(Prohibition of Insider Trading) Regulations 2015 as amended read with code of conduct for prohibition of insider trading of the Company the "Trading Window" for the designated persons connected persons and their immediate relatives to deal in the shares of the Company shall remain closed from Sunday October 01 2023 up to 48 hours after the declaration of Audited Financial Results of the Company by the Board for the quarter ending September 30 2023 (both days inclusive).
Mon, 25 Sep 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizers Report and e-voting result of 28th Annual General Meeting of Bafna pharmaceuticals Limited for the FY 2022-23
Sat, 23 Sep 2023
Announcement under Regulation 30 (LODR)-Resignation of Director
Shri Kamlesh Kumar Babulal DIN: 01218959 vide his letter dated September 09 2023 has resigned as Non-Executive Independent Director from the Board of Bafna Pharmaceuticals Limited with immediate effect on personal grounds.Shri Kamlesh Kumar Babulal was Chairperson of Nomination and Remuneration Committee and member of Audit Committee and Social Responsibility Committee of the Company.

Bafna Pharmaceuticals Ltd. Technical Scans

View details >>
Mon, 25 Sep 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days

Bafna Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,813.38 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. 65,264.13 1,928.35 +3.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 51.80 1,928.35 +3.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.92 1,928.35 +3.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,928.35 +3.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,928.35 +3.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,928.35 +3.4%

Bafna Pharmaceuticals Ltd. FAQ's

What is Bafna Pharma share price?
Can I buy Bafna Pharma shares now?
What is the Market Cap of Bafna Pharma?
What are the key metrics to analyse Bafna Pharma?
What is the 52 Week High and Low of Bafna Pharma?